Thalassaemia International Federation and Hemanext® Inc. Announce New Strategic Alliance
Organizations create partnership to support the needs of people living with hemoglobin disorders.
Lexington, MA, June 11, 2020 –(PR.com)– The Thalassaemia International Federation (TIF), a worldwide organization dedicated to ensuring equal access to quality healthcare for every patient with thalassaemia and other hemoglobin disorders across the world, and Hemanext Inc., a privately held medical technology company dedicated to improving patients’ quality of life by delivering a better red blood cell (RBC) replacement therapy, today announced a new strategic alliance on behalf of people living with thalassaemia.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
